Glycosyl phosphatidylinositol-anchored proteins and HIV infection

Massimo Alfano, Luca Cassetta, Guido Poli

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In addition to CD4 and chemokine receptors glycosyl phosphatidylinositol- anchored proteins (GPI-APs) have been involved in the regulation of the human immunodeficiency virus (HIV) life cycle. In this article we will review the mechanisms underlying the anti-HIV activities regulated by GPI-APs and their ligands. Understanding how GPI-APs finely regulate HIV infection and replication may unravel novel and complementary strategies to combat and control HIV infection.

Original languageEnglish
Pages (from-to)598-604
Number of pages7
JournalLetters in Drug Design and Discovery
Volume3
Issue number9
DOIs
Publication statusPublished - 2006

Fingerprint

Glycosylphosphatidylinositols
Virus Diseases
HIV
Proteins
CD4 Antigens
Chemokine Receptors
Virus Replication
Life Cycle Stages
Ligands

Keywords

  • GPI (Glycosyl Phosphatidylinositol)
  • GPI-AP (Glycosyl Phosphatidylinositol- Anchored Protein)
  • HIV (Human Immunodeficiency Virus)
  • PTXB (pertussis toxin B-oligomer)
  • uPA (urokinase plasminogen activator)

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Drug Discovery
  • Molecular Medicine

Cite this

Glycosyl phosphatidylinositol-anchored proteins and HIV infection. / Alfano, Massimo; Cassetta, Luca; Poli, Guido.

In: Letters in Drug Design and Discovery, Vol. 3, No. 9, 2006, p. 598-604.

Research output: Contribution to journalArticle

@article{ffbdb8ff489044aebaf897a69232c94f,
title = "Glycosyl phosphatidylinositol-anchored proteins and HIV infection",
abstract = "In addition to CD4 and chemokine receptors glycosyl phosphatidylinositol- anchored proteins (GPI-APs) have been involved in the regulation of the human immunodeficiency virus (HIV) life cycle. In this article we will review the mechanisms underlying the anti-HIV activities regulated by GPI-APs and their ligands. Understanding how GPI-APs finely regulate HIV infection and replication may unravel novel and complementary strategies to combat and control HIV infection.",
keywords = "GPI (Glycosyl Phosphatidylinositol), GPI-AP (Glycosyl Phosphatidylinositol- Anchored Protein), HIV (Human Immunodeficiency Virus), PTXB (pertussis toxin B-oligomer), uPA (urokinase plasminogen activator)",
author = "Massimo Alfano and Luca Cassetta and Guido Poli",
year = "2006",
doi = "10.2174/157018006778341183",
language = "English",
volume = "3",
pages = "598--604",
journal = "Letters in Drug Design and Discovery",
issn = "1570-1808",
publisher = "Bentham Science Publishers B.V.",
number = "9",

}

TY - JOUR

T1 - Glycosyl phosphatidylinositol-anchored proteins and HIV infection

AU - Alfano, Massimo

AU - Cassetta, Luca

AU - Poli, Guido

PY - 2006

Y1 - 2006

N2 - In addition to CD4 and chemokine receptors glycosyl phosphatidylinositol- anchored proteins (GPI-APs) have been involved in the regulation of the human immunodeficiency virus (HIV) life cycle. In this article we will review the mechanisms underlying the anti-HIV activities regulated by GPI-APs and their ligands. Understanding how GPI-APs finely regulate HIV infection and replication may unravel novel and complementary strategies to combat and control HIV infection.

AB - In addition to CD4 and chemokine receptors glycosyl phosphatidylinositol- anchored proteins (GPI-APs) have been involved in the regulation of the human immunodeficiency virus (HIV) life cycle. In this article we will review the mechanisms underlying the anti-HIV activities regulated by GPI-APs and their ligands. Understanding how GPI-APs finely regulate HIV infection and replication may unravel novel and complementary strategies to combat and control HIV infection.

KW - GPI (Glycosyl Phosphatidylinositol)

KW - GPI-AP (Glycosyl Phosphatidylinositol- Anchored Protein)

KW - HIV (Human Immunodeficiency Virus)

KW - PTXB (pertussis toxin B-oligomer)

KW - uPA (urokinase plasminogen activator)

UR - http://www.scopus.com/inward/record.url?scp=33750049020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33750049020&partnerID=8YFLogxK

U2 - 10.2174/157018006778341183

DO - 10.2174/157018006778341183

M3 - Article

AN - SCOPUS:33750049020

VL - 3

SP - 598

EP - 604

JO - Letters in Drug Design and Discovery

JF - Letters in Drug Design and Discovery

SN - 1570-1808

IS - 9

ER -